Tag: NASDAQ
Han Kun advises 3SBio in landmark Pfizer licensing deal
3SBio inks major licensing deal with Pfizer for cancer drug SSGJ-707
Four law firms advise on Hotel101 SPAC listing
Milbank, Appleby, Loeb & Loeb, and Dahui Lawyers aided the merger agreement between Hotel101 Global, a Singaporean hotel operator, and JVSPAC Acquisition, a Hong Kong SPAC
VinFast paves way for Viet listings in US
Vietnamese law firm YKVN and international counterpart Latham & Watkins have assisted carmaker VinFast in a merger and Nasdaq listing
China Business Law Awards 2023
China Business Law Journal reveals its top performing law firms of 2022
S&R counsels chemical firm Solenis in USD4.6bn merger with Diversey
S&R Associates is representing leading global chemical producer Solenis, a portfolio company of Platinum Equity
China’s YishengBio eyes US capital markets via SPAC route
Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023
Tims China merges with Silver Crest to debut on Nasdaq
Tims China started to sell its shares on the Nasdaq after closing a merger with blank cheque company Silver Crest Acquisition Corp and at the same time received nearly USD200 million of additional financing
NaaS charges into Nasdaq on short-cut
NaaS Technology has been listed on Nasdaq through a merger with US company RISE Education Cayman in a deal that makes NaaS the third China concepts stock to go public in the US this year and the first IPO for an electric-vehicle charging-services provider
Capital punishment
Chinese IPOs overseas have consistently outperformed those of other nations, but a rash of scandals and suspected frauds has threatened to end the bull run.
